FI37172A - Process for the preparation of N-substituted 2,2-disubstituted-1,3-propanediol dicarbamates - Google Patents

Process for the preparation of N-substituted 2,2-disubstituted-1,3-propanediol dicarbamates

Info

Publication number
FI37172A
FI37172A FI148461A FI148461A FI37172A FI 37172 A FI37172 A FI 37172A FI 148461 A FI148461 A FI 148461A FI 148461 A FI148461 A FI 148461A FI 37172 A FI37172 A FI 37172A
Authority
FI
Finland
Prior art keywords
disubstituted
substituted
preparation
dicarbamates
propanediol
Prior art date
Application number
FI148461A
Other languages
Finnish (fi)
Inventor
Powell Leo Sylvester
Original Assignee
Carter Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carter Prod Inc filed Critical Carter Prod Inc
Priority to FI148461A priority Critical patent/FI37172A/en
Publication of FI37172A publication Critical patent/FI37172A/en

Links

FI148461A 1961-08-21 1961-08-21 Process for the preparation of N-substituted 2,2-disubstituted-1,3-propanediol dicarbamates FI37172A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI148461A FI37172A (en) 1961-08-21 1961-08-21 Process for the preparation of N-substituted 2,2-disubstituted-1,3-propanediol dicarbamates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI148461A FI37172A (en) 1961-08-21 1961-08-21 Process for the preparation of N-substituted 2,2-disubstituted-1,3-propanediol dicarbamates

Publications (1)

Publication Number Publication Date
FI37172A true FI37172A (en) 1967-09-11

Family

ID=36901370

Family Applications (1)

Application Number Title Priority Date Filing Date
FI148461A FI37172A (en) 1961-08-21 1961-08-21 Process for the preparation of N-substituted 2,2-disubstituted-1,3-propanediol dicarbamates

Country Status (1)

Country Link
FI (1) FI37172A (en)

Similar Documents

Publication Publication Date Title
CH457473A (en) Process for the preparation of 9,10-dihydroergovaline
DK123976B (en) Process for the preparation of 1-amino-adamantane hydrochloride.
DK105064C (en) Process for the preparation of N-substituted phenylsulfonyl-N'-cycloalkylureas.
FI37172A (en) Process for the preparation of N-substituted 2,2-disubstituted-1,3-propanediol dicarbamates
DK106090C (en) Process for the preparation of 3-halogen-Δ <5> -19-nor-androstenes.
CH407981A (en) Process for the preparation of isoprene
CH454853A (en) Process for the preparation of N-substituted 2,3-polymethylene indoles
FR1302193A (en) Process for the preparation of 1.3-dialkyl-cyclobutenolones
FI33636A (en) Process for the preparation of N, N'-diarylacetamidines
CH432487A (en) Process for the preparation of mononitro-1,3,5-trialkylbenzene
FI36871A (en) Process for the preparation of dibenzodiazepinones
FI33735A (en) Process for the preparation of 6-demethyltetracycline
FI35821A (en) Process for the preparation of trialoxybenzyl-1-piperazines
DK98063C (en) Process for the preparation of 2-chloro-10- (3'-dimethylamino-propyl) -phenthiazine.
DK98062C (en) Process for the preparation of 2-chloro-10- (3'-dimethylamino-propyl) -phenthiazine.
FR1311541A (en) Process for the preparation of new trialkoxy-3,4,5 cinnamides
DK101740C (en) Process for the preparation of N-benzenesulfonyl-N'-cycloheptylurea derivatives.
DK100954C (en) Process for the preparation of 4-methyl-6-isobutenyl-pyrone- (2).
DK116058B (en) Process for the preparation of 5-phenyl-2-ethylamino-oxazolinone- (4).
DK90011C (en) Process for the preparation of N-sulfanilyl-N'-butylurea.
FR1234769A (en) Preparation of 3, 3, 3-trifluoropropene
DK100570C (en) Process for the preparation of naphthopyran-2-spiro-2'-3'-methyl-benzopyrans.
DK97181C (en) Process for the preparation of 3-alkyl-benzoxazole-2-spiro-2'-3'-methyl-benzopyrans.
DK98298C (en) Process for the preparation of 3-alkylbenzothiazole-2-spiro-2'-3'-methylbenzopyrans.
FI35478A (en) Process for the preparation of a therapeutically effective 17β-hydroxy-17alpha-methyl-androstane- (3,2-c) -isooxazole